190 related articles for article (PubMed ID: 20336302)
1. Effects of a 6-month course of tamsulosin for chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized trial.
Chen Y; Wu X; Liu J; Tang W; Zhao T; Zhang J
World J Urol; 2011 Jun; 29(3):381-5. PubMed ID: 20336302
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
Nickel JC; Narayan P; McKay J; Doyle C
J Urol; 2004 Apr; 171(4):1594-7. PubMed ID: 15017228
[TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial.
Alexander RB; Propert KJ; Schaeffer AJ; Landis JR; Nickel JC; O'Leary MP; Pontari MA; McNaughton-Collins M; Shoskes DA; Comiter CV; Datta NS; Fowler JE; Nadler RB; Zeitlin SI; Knauss JS; Wang Y; Kusek JW; Nyberg LM; Litwin MS;
Ann Intern Med; 2004 Oct; 141(8):581-9. PubMed ID: 15492337
[TBL] [Abstract][Full Text] [Related]
4. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
Mehik A; Alas P; Nickel JC; Sarpola A; Helström PJ
Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
[TBL] [Abstract][Full Text] [Related]
5. [Tamsulosin for the treatment of chronic abacterial prostatitis].
Chen XS; Ye ZQ; Zeng XY
Zhonghua Nan Ke Xue; 2002; 8(1):51-3. PubMed ID: 12479050
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study.
Matsukawa Y; Naito Y; Funahashi Y; Ishida S; Fujita T; Tochigi K; Kato M; Gotoh M
Neurourol Urodyn; 2020 Sep; 39(7):1994-2002. PubMed ID: 32648985
[TBL] [Abstract][Full Text] [Related]
7. Treatment of refractory category III nonbacterial chronic prostatitis/chronic pelvic pain syndrome with intraprostatic injection of onabotulinumtoxinA: a prospective controlled study.
Abdel-Meguid TA; Mosli HA; Farsi H; Alsayyad A; Tayib A; Sait M; Abdelsalam A
Can J Urol; 2018 Apr; 25(2):9273-9280. PubMed ID: 29680006
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Palmitoylethanolamide, Epilobium and Calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III.
Morgia G; Lo Giudice A; Carrino M; Voce S; Cocci A; Reale G; Minervini A; Cimino S; Russo GI; Zingone F
Arch Ital Urol Androl; 2024 Jun; 96(2):12582. PubMed ID: 38934521
[TBL] [Abstract][Full Text] [Related]
9. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
Iwamura H; Koie T; Soma O; Matsumoto T; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
BMC Urol; 2015 Dec; 15():120. PubMed ID: 26643109
[TBL] [Abstract][Full Text] [Related]
10. Clinical study of duloxetine hydrochloride combined with doxazosin for the treatment of pain disorder in chronic prostatitis/chronic pelvic pain syndrome: An observational study.
Zhang M; Li H; Ji Z; Dong D; Yan S
Medicine (Baltimore); 2017 Mar; 96(10):e6243. PubMed ID: 28272220
[TBL] [Abstract][Full Text] [Related]
11. Men suffering from category III chronic prostatitis may benefit from N-acetylcysteine as an adjunct to alpha-blockers.
Yaryari AM; Mousavibahar SH; Amirhassani S; Bagheri M; Mohammadi Y; Mehrpooya M
Low Urin Tract Symptoms; 2022 May; 14(3):199-207. PubMed ID: 35068061
[TBL] [Abstract][Full Text] [Related]
12. A phase II, randomized, single-blinded, placebo-controlled clinical trial on the efficacy of Curcumina and Calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III.
Morgia G; Russo GI; Urzì D; Privitera S; Castelli T; Favilla V; Cimino S
Arch Ital Urol Androl; 2017 Jun; 89(2):110-113. PubMed ID: 28679180
[TBL] [Abstract][Full Text] [Related]
13. [Effects of Huafenqinutang and vardenafil for treatment of chronic prostatitis/chronic pelvic pain syndrome with concomitant erectile dysfunction].
Lin ZF; Chen BT; Zeng K; Lan HM; Wun J
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):532-4. PubMed ID: 17545052
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
Zhang K; Liu Y; Yang W; Wang J; Yang J; Zhang G; Bai W; Chen S
Urology; 2021 Jul; 153():264-269. PubMed ID: 33482135
[TBL] [Abstract][Full Text] [Related]
15. Acupuncture combined with tamsulosin hydrochloride sustained-release capsule in the treatment of chronic prostatitis/chronic pelvic pain syndrome: A study protocol for a randomized controlled trial.
Wang JS; Yang J; Deng S; Yu XD; Bao BH; Liu RJ; Li HS
Medicine (Baltimore); 2020 Mar; 99(12):e19540. PubMed ID: 32195959
[TBL] [Abstract][Full Text] [Related]
16. Immunostimulation in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a one-year prospective, double-blind, placebo-controlled study.
Wagenlehner FM; Ballarini S; Naber KG
World J Urol; 2014 Dec; 32(6):1595-603. PubMed ID: 24482313
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tamsulosin vs tamsulosin/sildenafil effectiveness in the treatment of erectile dysfunction in patients affected by type III chronic prostatitis.
Cantoro U; Catanzariti F; Lacetera V; Quaresima L; Muzzonigro G; Polito M
Arch Ital Urol Androl; 2013 Sep; 85(3):109-12. PubMed ID: 24085230
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
Xia D; Wang P; Chen J; Wang S; Jiang H
Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
[TBL] [Abstract][Full Text] [Related]
19. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
Cheah PY; Liong ML; Yuen KH; Teh CL; Khor T; Yang JR; Yap HW; Krieger JN
J Urol; 2003 Feb; 169(2):592-6. PubMed ID: 12544314
[TBL] [Abstract][Full Text] [Related]
20. Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: results of a prospective pilot double-blind and randomized placebo-controlled study.
Falahatkar S; Shahab E; Gholamjani Moghaddam K; Kazemnezhad E
BJU Int; 2015 Oct; 116(4):641-9. PubMed ID: 25307409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
